SYRE
SYRE clinical trials: Spyre Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Spyre Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 8
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SYRE on the catalyst calendar · SYRE registry changes
- Primary completion Oct 2027Sponsor estimatePhase 2NCT07766005A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)Spyre Therapeutics, Inc. · Hidradenitis Suppurativa (HS)RecruitingSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 2NCT07012395A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisSpyre Therapeutics, Inc. · Ulcerative ColitisRecruitingSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2, 2029Sponsor estimatePhase 2NCT07652294Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDSpyre Therapeutics, Inc. · Ulcerative ColitisEnrolling by invitationSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 19, 2026ActualPhase 1NCT06672718A Study of SPY002-091 in Healthy VolunteersSpyre Therapeutics, Inc. · HealthyCompletedSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 28, 2026ActualPhase 1NCT06622070A Study of SPY002-072 in Healthy VolunteersSpyre Therapeutics, Inc. · HealthyCompletedSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 31, 2026Sponsor estimatePhase 2NCT07148414A Study of SPY072 in Rheumatic DiseaseSpyre Therapeutics, Inc. · Rheumatoid ArthritisActive, not recruitingSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 18, 2026Sponsor estimatePhase 1NCT06873724A Study of SPY003-207 in Healthy VolunteersSpyre Therapeutics, Inc. · HealthyActive, not recruitingSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2026ActualPhase 1NCT06448247A Study of SPY001-001 in Healthy VolunteersSpyre Therapeutics, Inc. · HealthyCompletedSYRELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner